Last reviewed · How we verify

NCT03610815

Community I-STAR Mozambique: Community Implementation of SBIRT Using Technology for Alcohol Use Reduction in Mozambique

Completed Phase 4 Last updated 6 October 2025
What this trial tests

Phase 4 trial testing Screening, Brief Intervention, Referral to Treatment in mSBIRT - Mobile Screening, Brief Intervention, Referral to Treatment in 540 participants. Completed in 31 August 2025.

Timeline
1 October 2021
Primary endpoint
31 August 2025
31 August 2025

Quick facts

Lead sponsorNew York State Psychiatric Institute
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment540
Start date1 October 2021
Primary completion31 August 2025
Estimated completion31 August 2025
Sites1 location across Mozambique

Drugs / interventions tested

Conditions studied

Sponsor

New York State Psychiatric Institute

Who can join

18 and older, any sex, with mSBIRT - Mobile Screening, Brief Intervention, Referral to Treatment or SBIRT-CTS - Screening, Brief Intervention, Referral to Treatment Conventional Training and Supervision Strategy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hazardous drinking (HD) is a major public health burden worldwide with significant morbidity and mortality. To reduce HD, the World Health Organization (WHO) recommends using Screening, Brief Intervention, Referral to Treatment (SBIRT). Mobile health technology (mHealth), such as the mSBIRT app, is a promising tool for widespread cost-effective delivery of evidence-based HDS by community health workers (CHWs) because of its potential to increase fidelity, effectiveness, and sustainability. Community I-STAR Mozambique comprises three phases: 1) mSBIRT adaptation, 2) a cluster-randomized trial, and 3) scale-up of the most cost-effective intervention. Community I-STAR Mozambique will scale-up a cost effective, sustainable program and inform policy applicable to Mozambique and other LMICs.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries.
    Greene MC, Kane J, Alto M, Giusto A, et al · · 2023 · cited 7× · PMID 37158538 · DOI 10.1002/14651858.cd013350.pub2
  2. Scale-Up Study Protocol of the Implementation of a Mobile Health SBIRT Approach for Alcohol Use Reduction in Mozambique.
    Suleman A, Mootz JJ, Feliciano P, Nicholson T, et al · · 2021 · cited 6× · PMID 34126774 · DOI 10.1176/appi.ps.202000086

Verify or expand the search:

Other New York State Psychiatric Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03610815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing